NHS England and NICE issue Spinraza Q&As

Published Date
19/05/2020
Author
Laura Burge
Category
Care & Support
Spinraza SMA treatment

NICE, NHS England and NHS Improvement have taken advice from clinical experts and consulted with patient advisory groups Muscular Dystrophy UK, Treat SMA, and SMA UK to produce two new question-and-answer documents relating to the SMA treatment Spinraza.

The first document, which answers questions relating to access for children, can be accessed here.

The second document answers questions about the Managed Access Agreement (MAA) for Spinraza for treating SMA. You can read the information here.

Keep in touch